2.7 Biological age screening
Biological age tests are a new frontier in personalized health, using various biomarkers to estimate an individual’s physiological health status in relation to their chronological age. These tests aim to provide a more accurate measure of health and longevity than chronological age alone, which is a poor predictor of disease and death. While a universal standard has not yet been established, the primary methodologies include epigenetic clocks, telomere length measurement, and composite blood biomarker panels. Each approach offers unique insights into the aging process, influenced by a person’s genetics, lifestyle, and environment.
The future of biological age testing lies in moving from research tools to clinically validated diagnostic and predictive instruments. While consumer tests are widely available, they currently lack the rigorous validation and standardization needed for widespread clinical adoption (Smith, 2024). Future advancements, driven by AI and machine learning, will likely improve the accuracy and predictive power of these tests, allowing them to identify specific tissues or organs that are aging faster than others. The hope is that these tests will become a standard part of health assessments, guiding personalized interventions to slow the aging process and delay the onset of age-related diseases. However, ethical considerations, including data privacy and the potential for over-diagnosis and patient anxiety, must be addressed to ensure these technologies benefit public health.
More details about the various tests can be found in the Innovation in Prevention Chapter.